HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bifidobacterium with the role of 5-hydroxytryptophan synthesis regulation alleviates the symptom of depression and related microbiota dysbiosis.

Abstract
Depression disorder is rapidly advancing worldwide, and therapeutic strategy through gut-brain axis has been proven to be effective in the treatment. Here we studied the effect of lactic acid bacteria (LAB) treatment on depression. C57BL/6J mice were administered with LAB during a 5-week chronic unpredictable mild stress. Bifidobacterium longum subsp. infantis E41 and Bifidobacterium breve M2CF22M7, which improved the expression of Tph1 and secretion of 5-hydroxytryptophan (5-HTP) in RIN14B cells, significantly reduced depressive behaviors of mice in the forced swim test, sucrose preference test and step-down test, as well as increased the level of 5-hydroxytryptamine and brain-derived neurotrophic factor concentration in brain. Besides, M2CF22M7 reduced the serum corticosterone level. E41 increased cecal butyrate level, which significantly and positively correlated with some depression-related indexes. Using 16S rRNA-amplicon sequencing of faces, E41 and M2CF22M7 were found to improve the chronic-stress-induced microbial dysbiosis. They also normalized the host's pathways involving metabolism and gene information processing. These results indicate that Bifidobacterium E41 and M2CF22M7 have an antidepressant effect in mice partly in a 5-HTP dependent and microbiota-regulating manner. Nurturing the gut microbiota with these strains may become an emerging therapeutic way for mood disorder.
AuthorsPeijun Tian, Gang Wang, Jianxin Zhao, Hao Zhang, Wei Chen
JournalThe Journal of nutritional biochemistry (J Nutr Biochem) Vol. 66 Pg. 43-51 (04 2019) ISSN: 1873-4847 [Electronic] United States
PMID30743155 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 Elsevier Inc. All rights reserved.
Chemical References
  • Butyrates
  • Fatty Acids, Volatile
  • 5-Hydroxytryptophan
  • Tryptophan Hydroxylase
  • tph1 protein, rat
Topics
  • 5-Hydroxytryptophan (biosynthesis)
  • Animals
  • Behavior, Animal
  • Bifidobacterium
  • Butyrates (metabolism)
  • Depression (microbiology, therapy)
  • Dysbiosis (therapy)
  • Fatty Acids, Volatile (metabolism)
  • Feces (microbiology)
  • Gastrointestinal Microbiome
  • Hippocampus (metabolism)
  • Male
  • Mice, Inbred C57BL
  • Probiotics (pharmacology)
  • Rats
  • Stress, Psychological (therapy)
  • Tryptophan Hydroxylase (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: